2025-11-30 false 1.0 Zoho No description of principal activity 2024-12-01 10578925 2024-12-01 2025-11-30 10578925 uk-bus:Director1 2024-12-01 2025-11-30 10578925 uk-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 10578925 uk-bus:Micro-entities 2024-12-01 2025-11-30 10578925 uk-bus:FullAccounts 2024-12-01 2025-11-30 10578925 uk-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 10578925 uk-bus:RegisteredOffice uk-countries:UnitedKingdom 2024-12-01 2025-11-30 10578925 2024-12-01 10578925 2025-11-30 10578925 uk-core:CurrentFinancialInstruments 2025-11-30 10578925 uk-core:Non-currentFinancialInstruments 2025-11-30 10578925 2023-12-01 2024-11-30 10578925 2024-11-30 10578925 uk-core:CurrentFinancialInstruments 2024-11-30 10578925 uk-core:Non-currentFinancialInstruments 2024-11-30 iso4217:GBP xbrli:pure
Company Registration Number: 10578925 (NJR Medical Ltd)
NJR Medical Ltd

Unaudited financial statements for the year ended 30 November 2025

Company information

Company Name: NJR Medical Ltd

Company Registration Number: 10578925.

The companys registered office is: 557 Otley Road, Adel , Leeds, LS16 7PH, United Kingdom.

NJR Medical Ltd

Unaudited financial statements for the year ended 30 November 2025


Balance Sheet • (as at 30 November 2025)
Account 2025 2024
(£) (£) (£) (£)
Called up share capital not paid 0 0
Fixed assets 0 0
Current assets 97972 71646
Prepayments and accrued income 0 0
Creditors: amounts falling due within one year ( 11551 ) ( 3311 )
Net current Assets (liabilities) 86421 68335
Total assets less current liabilities 86421 68335
Creditors: amounts falling due after more than one year 0 0
Provisions for liabilities 0 0
Accrual and deferred income 0 0
Net Assets (liabilities) 86421 68335
Capital and Reserves 86423 68335

NJR Medical Ltd

Unaudited financial statements for the year ended 30 November 2025


Notes to the accounts
General Information

NJR Medical Ltd is a private company, limited by shares, registered in England and Wales, registration number 10578925, registration address 557 Otley Road, Adel, Leeds, LS16 7PH, United Kingdom. The presentation currency is £ sterling. The principal activity of the company during the year was the provision of medical services.

  1. Accounting policies
    Significant accounting policies
    1. Statement Of Compliance

      These financial statements have been prepared in compliance with FRS 105 - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

    2. Basis Of Preparation

      The financial statements have been prepared under the historical cost convention. They are presented in pounds sterling (£), which is the company’s functional currency. Amounts are presented in whole pounds.

    The financial statements are prepared in Sterling which is the functional currency of the company.

  2. Average number of employees

    During the year the average number of employees was (2025: 1).

For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

NJR Medical Ltd

Unaudited financial statements for the year ended 30 November 2025


Directors responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476;

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.

The financial statements were approved by the director on 10 September 2026 and were signed by:

Director:-

Nicolas Raynor

10 September 2026